PACB
Pacific Biosciences of California Inc (PACB)
Healthcare • NASDAQ • $1.41-14.55%
- Symbol
- PACB
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $1.41
- Daily Change
- -14.55%
- Market Cap
- $437.79M
- Trailing P/E
- N/A
- Forward P/E
- -3.53
- 52W High
- $2.73
- 52W Low
- $0.85
- Analyst Target
- $2.46
- Dividend Yield
- N/A
- Beta
- 2.40
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company…
Company websiteResearch PACB on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.